世界中医药
文章摘要
引用本文:迟鹏1,郝庆2,姚艳春1,孙玉兰1,许德颖3,王嘉怡4.胡黄连苷Ⅱ联合曲美替尼对HT-29细胞凋亡和上皮细胞间质转化的影响[J].世界中医药,2021,(17):.  
胡黄连苷Ⅱ联合曲美替尼对HT-29细胞凋亡和上皮细胞间质转化的影响
Effects of Coprininoside Ⅱ Combined with Trametinib in HT-29 Cells Apoptosis and EMT
投稿时间:2021-07-06  
DOI:10.3969/j.issn.1673-7202.2021.17.012
中文关键词:  胡黄连苷Ⅱ  曲美替尼  结直肠癌  miR-4319  增殖  凋亡  上皮间质转化  HT-29细胞
English Keywords:Cuberitin II  Trametinib  Colorectal cancer  miR-4319  Proliferation  Apoptosis  EMT  HT-29 cells
基金项目:国家自然科学基金项目(81770406)
作者单位
迟鹏1,郝庆2,姚艳春1,孙玉兰1,许德颖3,王嘉怡4 1 辽宁省鞍山市中心医院消化内科鞍山114001 2 中国医科大学附属盛京医院消化内科沈阳110000 3 辽宁省盘锦市中心医院放疗科盘锦1240104湘南学院郴州423000 
摘要点击次数: 228
全文下载次数: 0
中文摘要:
      目的:研究胡黄连苷Ⅱ联合曲美替尼通过miR-4319对结直肠癌细胞HT-29凋亡和上皮细胞间质转化(EMT)的影响。方法:将结直肠癌细胞HT-29分成6组,分别为对照组、曲美替尼组、胡黄连苷Ⅱ组、联合组、miR-NC抑制组、miR-4319抑制组,n=9。采用CCK-8实验检测细胞增殖,流式细胞术检测细胞凋亡,Western Blotting法检测Vimentin、E-cadherin、Bax、C-Caspase-3蛋白表达,qRT-PCR检测miR-4319表达。比较6个组的检测结果。结果:与对照组比较,曲美替尼组、胡黄连苷Ⅱ组、联合组的细胞成活率和Vimentin的表达均减少(均P<0.05),而凋亡率和Bax、C-Caspase-3、E-cadherin的表达均增加(均P<0.05);与miR-NC抑制组比较,miR-4319抑制组的细胞成活率、Vimentin的表达均显著增加(均P<0.05),细胞凋亡率和Bax、C-Caspase-3、E-cadherin蛋白表达却显著减少(均P<0.05);qRT-PCR结果显示,与对照组比较,曲美替尼组、胡黄连苷Ⅱ组细胞中miR-4319的表达增多(均P<0.05)。结论:胡黄连苷Ⅱ联合曲美替尼通过上调miR-4319诱导结直肠癌细胞HT-29凋亡,并抑制细胞EMT。
English Summary:
      To study the effects of cucurbitacin Ⅱ combined with trametinib on the colorectal cancer cells HT-29 apoptosis and epithelial-mesenchymal transition(EMT) through miR-4319.Methods:Colorectal cancer cells HT-29 were divided into 6 groups,namely the a control group,a trametinib group,a coprininoside II group,a combination group,an miR-NC inhibition group,and an miR-4319 inhibition group(n=9).In 6 groups,CCK-8 experiment was used to detect cell proliferation,flow cytometry was used to detect cell apoptosis,Western blot was used to detect the protein expression of Vimentin,E-cadherin,Bax,and C-Caspase-3,and the expression of miR-4319 was detected by qRT-PCR.Compare the experimental results of the 6 groups.Results:Compared with the control group,the cell survival rate,and the expression of Vimentin in the trametinib group,the berberine Ⅱ group and the combination group were reduced(P<0.05),while the apoptosis rate and the expression of Bax,C-Caspase-3,E-cadherin both increased(P<0.05); compared with the miR-NC inhibition group,the cell survival rate and Vimentin expression in the miR-4319 inhibition group were significantly increased(P<0.05).However,the apoptosis rate,the expression of Bax,C-Caspase-3 and E-cadherin were significantly reduced(P<0.05); qRT-PCR results showed that compared with the control group,the expression of miR-4319 in the cells of the trametinib group and berberineⅡgroup increased(P<0.05).Conclusion:The combination of cucurbitacin Ⅱ and trametinib induces the apoptosis and inhibits cell EMT of colorectal cancer cells HT-29 by up-regulating miR-4319.
查看全文  查看/发表评论  下载PDF阅读器